🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareFDA compounding enforcement update — June 2026 guidance document Page 16

FDA compounding enforcement update — June 2026 guidance document

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 336 replies 53,782 viewsPage 16 of 20
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Mar 23, 2024 at 5:31 PM#76
raj_cambridge said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is where I part company with the consensus forming above. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

Last edited: Mar 23, 2024 at 11:31 PM
25 0julia.endo, JessicaM_2024, TomFromTexas and 22 others
Reply Quote Save Share Report
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Mar 24, 2024 at 3:09 AM#77
raj_cambridge said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Correct me if the detail matters more than I have assumed.

24 24Dr.Martinez, mike_mod, SarahChen_PharmD and 21 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Mar 24, 2024 at 12:47 PM#78

Found this through search years later and it is still the best discussion of the question, so adding one thing. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

23 23Dr.PulmRoch, maya_sedona, stefan_berlin and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Mar 24, 2024 at 10:26 PM#79

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

22 22SaraMom3, Dr.MetabolicMD, RetaRick_CA and 19 others
Reply Quote Save Share Report
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Mar 25, 2024 at 8:05 AM#80
Dr.PathRoch said:
The useful move here is to separate what is established from what is widely repeated.

Can confirm. Same sequence, different timescale.

50 0RickReta_CO, PharmHunterJen, TomTeleRx and 47 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register